I would like to respond to the correspondence and communication submitted by Chaput
et al.
1
regarding the decision of the French Agency for Safety of Health Products (AFSSAPS)
to no longer approve Macrolane™ (Q-Med AB, Uppsala, Sweden) and other fillers for
aesthetic breast augmentation.- Chaput B.
- Chavoin J.P.
- Crouzet C.
- Grolleau J.L.
- Garrido I.
Macrolane is no longer allowed in aesthetic breast augmentation in France. Will this
decision extend to the rest of the world?.
J Plast Reconstr Aesthet Surg. 2011; https://doi.org/10.1016/j.bjps.2011.10.011
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Journal of Plastic, Reconstructive & Aesthetic SurgeryAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Macrolane is no longer allowed in aesthetic breast augmentation in France. Will this decision extend to the rest of the world?.J Plast Reconstr Aesthet Surg. 2011; https://doi.org/10.1016/j.bjps.2011.10.011
- Macrolane™ complications after breast augmentation: treatment and prevention.Eur J Plast Surg. 2011; (Published online 11 May 2011)
- Early clinical experience of hyaluronic acid gel for breast enhancement.J Plast Reconstr Aesthet Surg. 2011; 64: 722-729
- The imaging features of Macrolane™ in breast augmentation.Clin Radiol. 2011; 66: 977-983
- Macrolane injections for breast enhancement in un-diagnosed breast malignancy: a case report.J Plast Reconstr Aesthet Surg. 2011; 64: 1682-1683
Article info
Publication history
Published online: January 16, 2012
Identification
Copyright
© 2011 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Reply to discussion: Macrolane is no longer allowed in aesthetic breast augmentation in France. Will this decision extend to the rest of the world?Journal of Plastic, Reconstructive & Aesthetic SurgeryVol. 65Issue 4
- PreviewI would like to thank Dr. Per Heden, who has extensive experience of Macrolane, for this additional information. Since March 11, 2005, the precautionary principle is part of the French Republic constitution. The scandal PIP (Poly Implant Prothèse) is not the first crisis that led parliamentarians to that decision. The contaminated blood affair, mad cow diseases… have contributed to promote this basic principle a few years ago. This communication is not only the viewpoint of Chaput et al. but also of the AFSSAPS’ expert group who have considered that at the present time, the available scientific literature on hyaluronic acid injections close to the breast parenchyma was insufficient.
- Full-Text
- Preview
